Ultragenyx Pharmaceutical Inc. has announced the grant of 44,805 restricted stock units to 20 newly hired non-executive officers as part of their Ultragenyx Employment Inducement Plan. Approved by the company's compensation committee, these awards are intended as inducement material for new employees joining the company. The grant date for these stock units is May 16, 2025, and they will vest over a period of four years. Specifically, 25% of the shares will vest on each anniversary of the grant date, provided the employee remains continuously employed with Ultragenyx. This plan is in accordance with Nasdaq Listing Rule 5635(c)(4).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9455063-en) on May 20, 2025, and is solely responsible for the information contained therein.